Literature DB >> 16740651

Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics.

Wayne Ensign1, Nicole Hill, Christopher B Heward.   

Abstract

BACKGROUND: Our study seeks to clarify the extent of differences in analytical results, from a clinical perspective, among 4 leading technologies currently used in clinical reference laboratories for the analysis of LDL subfractions: gradient gel electrophoresis (GGE), ultracentrifugation-vertical auto profile (VAP), nuclear magnetic resonance (NMR), and tube gel electrophoresis (TGE).
METHODS: We collected 4 simultaneous blood samples from 40 persons (30 males and 10 females) to determine LDL subclasses in 4 different clinical reference laboratories using different methods for analysis. LDL subfractions were assessed according to LDL particle size and the results categorized according to LDL phenotype. We compared results obtained from the different technologies.
RESULTS: We observed substantial heterogeneity of results and interpretations among the 4 methods. Complete agreement among methods with respect to LDL subclass phenotyping occurred in only 8% (n = 3) of the persons studied. NMR and GGE agreed most frequently at 70% (n = 28), whereas VAP matched least often.
CONCLUSIONS: As measurement of LDL subclasses becomes increasingly important, standardization of methods is needed. Variation among currently available methods renders them unreliable and limits their clinical usefulness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740651     DOI: 10.1373/clinchem.2005.059949

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Lipoprint adequately estimates LDL size distribution, but not absolute size, versus polyacrylamide gradient gel electrophoresis.

Authors:  Krista A Varady; Benoît Lamarche
Journal:  Lipids       Date:  2011-09-21       Impact factor: 1.880

2.  Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy.

Authors:  Roger Mallol; Núria Amigó; Miguel A Rodríguez; Mercedes Heras; Maria Vinaixa; Núria Plana; Edmond Rock; Josep Ribalta; Oscar Yanes; Lluís Masana; Xavier Correig
Journal:  J Lipid Res       Date:  2015-01-07       Impact factor: 5.922

3.  Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles.

Authors:  C B Dias; N Amigo; L G Wood; X Correig; M L Garg
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

4.  Analysis of cholesterol levels in lipoprotein(a) with anion-exchange chromatography.

Authors:  Yuji Hirowatari; Hiroshi Yoshida; Hideo Kurosawa; Yuko Shimura; Hidekatsu Yanai; Norio Tada
Journal:  J Lipid Res       Date:  2009-10-30       Impact factor: 5.922

5.  Comparison of biomarkers of oxidative stress and cardiovascular disease in humans and chimpanzees (Pan troglodytes).

Authors:  Elaine N Videan; Christopher B Heward; Kajal Chowdhury; John Plummer; Yali Su; Richard G Cutler
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

Review 6.  Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.

Authors:  Stanley Ip; Alice H Lichtenstein; Mei Chung; Joseph Lau; Ethan M Balk
Journal:  Ann Intern Med       Date:  2009-04-07       Impact factor: 25.391

7.  Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles.

Authors:  Vasilis Tsimihodimos; Irene Gazi; Christina Kostara; Alexandros D Tselepis; Moses Elisaf
Journal:  Lipids       Date:  2007-04-11       Impact factor: 1.880

Review 8.  Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use.

Authors:  Samia Mora
Journal:  Circulation       Date:  2009-05-05       Impact factor: 29.690

9.  Developing high performance lipoprotein density profiling for use in clinical studies relating to cardiovascular disease.

Authors:  Craig D Larner; Ronald R Henriquez; Jeffrey D Johnson; Ronald D Macfarlane
Journal:  Anal Chem       Date:  2011-10-18       Impact factor: 6.986

10.  Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study.

Authors:  Sammy Y Chan; G B John Mancini; Andrew Ignaszewski; Jiri Frohlich
Journal:  BMC Clin Pharmacol       Date:  2008-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.